CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
97.06
-0.02 (-0.02%)
At close: Jun 9, 2026, 4:00 PM EDT
97.05
-0.01 (-0.01%)
After-hours: Jun 9, 2026, 7:59 PM EDT

CVS Health Stock Forecast

Stock Price Forecast

According to 28 analysts polled by S&P Global, CVS Health stock has a consensus rating of "Buy" and an average price target of $103.81. The average 1-year stock price forecast is 6.95% higher than the current stock price, while the lowest is $79 (-18.61%) and the highest is $140 (+44.24%).

Price Target: $103.81 (+6.95%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$79$103.81$105$140
Change-18.61%+6.95%+8.18%+44.24%

Analyst Ratings

The average analyst rating for CVS Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy171718181818
Buy777766
Hold454344
Sell000000
Strong Sell000000
Total282929282828

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
UBS
UBS
Buy
Maintains
$100$115
BuyMaintains$100$115+18.48%Jun 8, 2026
Mizuho Securities
Mizuho Securities
Buy
Maintains
$110$115
BuyMaintains$110$115+18.48%Jun 8, 2026
Wells Fargo
Wells Fargo
Buy
Maintains
$103
BuyMaintains$103+6.12%Jun 4, 2026
Morgan Stanley
Morgan Stanley
Buy
Maintains
$106$111
BuyMaintains$106$111+14.36%Jun 4, 2026
Truist Financial
Truist Financial
Buy
Maintains
$102$108
BuyMaintains$102$108+11.27%Jun 1, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
409.23B
from 399.83B
Increased by 2.35%
Revenue Next Year
425.82B
from 409.23B
Increased by 4.05%
EPS This Year
7.43
from 6.75
Increased by 10.06%
EPS Next Year
8.37
from 7.43
Increased by 12.66%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
290.91B321.63B356.62B370.66B399.83B409.23B
Revenue Growth
8.59%10.56%10.88%3.94%7.87%2.35%
Gross Profit
50.92B53.66B53.28B49.25B53.13B57.88B
Gross Margin
17.50%16.69%14.94%13.29%13.29%14.14%
Operating Income
14.16B15.74B14.07B8.02B10.02B15.74B
Net Income
8.00B4.31B8.34B4.61B1.77B7.97B
EPS
----6.757.43
EPS Growth
----24.54%10.06%
Forward PE
12.8810.679.397.7711.5413.06
Dividend / Share
2.002.202.422.662.662.64
Dividend Growth
-10.00%10.00%9.92%--0.76%
Free Cash Flow
14.78B11.94B11.08B6.91B5.93B7.97B
No. Analysts
-----20
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High425.8B
Avg409.2B
Low405.4B

Revenue Growth

Revenue Growth202620272028
High
6.5%
Avg
2.4%
Low
1.4%

EPS Forecast

EPS202620272028
High7.65
Avg7.43
Low7.35

EPS Growth

EPS Growth202620272028
High
13.3%
Avg
10.1%
Low
8.9%